Data / Form D filings / Savara Inc.
Savara Inc.: Form D filings
Savara Inc., a pharmaceuticals company in Austin, TX, filed 14 Form D notices with the SEC between 2009 and 2016. The latest, on July 18, 2016, reports an offering of $5 million with nothing sold yet.
Find out what Savara Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 900 S. CAPITAL OF TEXAS HIGHWAY, Suite 150, Austin, TX, 78746
- Phone
- (512) 961-1891
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1461492
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 18, 2016 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Mar 2, 2016 | Amendment | $21,006,246 | $20,671,246 | $335,000 | 206 | Dec 3, 2015 | sec.gov |
| Dec 17, 2015 | New notice | $21,006,246 | $18,544,474 | $2,461,772 | 125 | Dec 3, 2015 | sec.gov |
| Oct 16, 2014 | Amendment | $10,000,000 | $10,000,000 | $0 | 139 | Jun 5, 2014 | sec.gov |
| Oct 10, 2014 | New notice | $10,000,000 | $10,000,000 | $0 | 139 | Jun 5, 2014 | sec.gov |
| Jun 26, 2014 | Amendment | $5,000,000 | $4,493,581 | $506,419 | 56 | Jun 5, 2014 | sec.gov |
| Jun 10, 2014 | New notice | $5,000,000 | $4,493,581 | $506,419 | 56 | Jun 5, 2014 | sec.gov |
| Jun 26, 2013 | Amendment | $15,642,858 | $14,398,895 | $1,243,963 | 239 | May 30, 2012 | sec.gov |
| Jun 12, 2012 | New notice | $11,500,000 | $6,898,506 | $4,601,494 | 117 | May 30, 2012 | sec.gov |
| Sep 21, 2010 | Amendment | $1,420,929 | $1,420,929 | $0 | 23 | Dec 10, 2009 | sec.gov |
| Mar 11, 2010 | Amendment | $777,000 | $720,929 | $56,071 | 14 | Dec 10, 2009 | sec.gov |
| Dec 15, 2009 | Amendment | $777,000 | $645,000 | $132,000 | 13 | Dec 10, 2009 | sec.gov |
| Dec 15, 2009 | New notice | $777,000 | $656,157 | $120,843 | 13 | Dec 10, 2009 | sec.gov |
| Jun 8, 2009 | New notice | $1,399,155 | $833,000 | $566,155 | 13 | Jun 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nevan Elam | Director | |
| Yuri S. Pikover | Director | |
| Richard Hawkins | Director | |
| Joseph S. McCracken | Director | |
| Taneli S. Jouhikainen | Executive Officer | |
| Robert Neville | Executive Officer, Director | |
| Mike S. Ciesla | Executive Officer | |
| John S. Lord | Executive Officer | |
| Chris S. Marich | Executive Officer |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Jul 18, 2016 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Savara Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.